Difference between revisions of "Huang R, et al. Oncotarget (2017) cited as Ref 537 in DOI: 10.1038/s41392-020-0110-5 (Q9800)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 8, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 35351-35367, #quickstatements; #temporary_batch_1590074839150) |
||
(One intermediate revision by the same user not shown) | |||
Property / title | |||
+ | Cancer stem cells (CSCs) cervical CSCs and targeted therapies (English) | ||
Property / title: Cancer stem cells (CSCs) cervical CSCs and targeted therapies (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 35351-35367 | ||
Property / Page(s): 35351-35367 / rank | |||
+ | Normal rank |
Latest revision as of 15:44, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Huang R, et al. Oncotarget (2017) cited as Ref 537 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Huang R
0 references
Rofstad EK
0 references
2017
0 references
Oncotarget
0 references
8
0 references
Cancer stem cells (CSCs) cervical CSCs and targeted therapies (English)
0 references
35351-35367
0 references